已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Plasmonic nanobipyramids with photo-enhanced catalytic activity under near-infrared II window for effective treatment of breast cancer

材料科学 乳腺癌 红外线的 等离子体子 催化作用 窗口(计算) 治疗窗口 纳米技术 癌症 光电子学 医学 内科学 生物 计算机科学 光学 药理学 操作系统 物理 生物化学
作者
Li Zhao,Zhongqi Sun,Yi Wang,Jian Huang,Haitao Wang,Hui Li,Fei Chang,Yanyan Jiang
出处
期刊:Acta Biomaterialia [Elsevier BV]
卷期号:170: 496-506 被引量:25
标识
DOI:10.1016/j.actbio.2023.08.055
摘要

Nanozyme-based catalytic therapy is an effective method for cancer treatment, but insufficient catalytic activity presents a challenge in achieving optimal therapeutic outcomes. External light can provide an innovative approach to modulate nanozyme catalytic activity. Herein, we report on plasmonic gold nanobipyramid@cuprous oxide (Au NBP@Cu2O) nanozyme for the effective phototherapy of breast cancer. In the tumor microenvironment, Cu+-mediated Fenton-like reaction catalyzes the generation of toxic hydroxyl radicals (•OH) from endogenous hydrogen peroxide to induce apoptosis. Additionally, the Au NBP@Cu2O nanostructure improves the absorption performance of Au NBPs in the near-infrared II region through near-field enhancement of equipartite exciters and achieves a high photothermal conversion efficiency value of 58%. Remarkably, the Au NBP@Cu2O nanoheterostructure can capture hot electrons induced by equipartition excitations and promote electron-hole separation under 1064 nm laser irradiation, facilitating the production of more reactive oxygen species (ROS). The mechanism behind this enhanced catalytic activity was unraveled using femtosecond transient absorption spectroscopy. Both in vitro and in vivo investigations have demonstrated the efficacious tumor therapeutic potential of Au NBP@Cu2O nanozyme, particularly under 1064 nm laser irradiation. Furthermore, the proposed therapeutic approach has been proved to effectively block tumor metastasis, providing a promising strategy for the development of multifunctional nanotherapeutics to tackle metastatic tumors. STATEMENT OF SIGNIFICANCE: A highly effective plasmonic nanozyme has been developed to improve catalytic therapy for breast cancer. When exposed to 1064 nm laser irradiation, Au NBP@Cu2O nanozyme can promote the separation of hot electrons and holes thereby facilitating the production of reactive oxygen species. Hot electrons transfer behavior is unveiled by femtosecond transient absorption spectroscopy technique. This enhanced catalytic activity, along with the intrinsic photothermal effect, effectively kills tumor cells.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
芳华如梦完成签到 ,获得积分10
1秒前
陈1发布了新的文献求助10
2秒前
慕青应助彭蓬采纳,获得10
2秒前
辛勤雁凡发布了新的文献求助10
3秒前
CipherSage应助Moxley采纳,获得10
3秒前
jw2025完成签到 ,获得积分20
10秒前
痞老板死磕蟹黄堡完成签到 ,获得积分10
12秒前
科目三应助吃道格的恺特采纳,获得10
17秒前
1234完成签到,获得积分10
18秒前
18秒前
酷波er应助陈1采纳,获得10
18秒前
小蘑菇应助Zr采纳,获得20
19秒前
20秒前
煎饼果子完成签到 ,获得积分10
21秒前
jw2025关注了科研通微信公众号
23秒前
1234发布了新的文献求助10
23秒前
彭蓬完成签到,获得积分10
24秒前
sxd完成签到 ,获得积分10
24秒前
24秒前
27秒前
怕黑水蓝应助不嘻嘻嘻采纳,获得10
27秒前
彭蓬发布了新的文献求助10
29秒前
甜美千山完成签到 ,获得积分10
31秒前
刹那的颜色完成签到,获得积分10
32秒前
andrele完成签到,获得积分10
42秒前
Hello应助sunny66采纳,获得10
42秒前
科研通AI2S应助1234采纳,获得10
45秒前
ca完成签到 ,获得积分10
48秒前
50秒前
51秒前
lxy完成签到 ,获得积分10
55秒前
wjy完成签到 ,获得积分10
56秒前
56秒前
Moxley发布了新的文献求助10
57秒前
22发布了新的文献求助10
57秒前
123完成签到 ,获得积分10
57秒前
吃草草没完成签到 ,获得积分10
58秒前
shentaii完成签到,获得积分10
1分钟前
1分钟前
1分钟前
高分求助中
Standards for Molecular Testing for Red Cell, Platelet, and Neutrophil Antigens, 7th edition 1000
HANDBOOK OF CHEMISTRY AND PHYSICS 106th edition 1000
ASPEN Adult Nutrition Support Core Curriculum, Fourth Edition 1000
Signals, Systems, and Signal Processing 610
脑电大模型与情感脑机接口研究--郑伟龙 500
GMP in Practice: Regulatory Expectations for the Pharmaceutical Industry 500
简明药物化学习题答案 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6299032
求助须知:如何正确求助?哪些是违规求助? 8116104
关于积分的说明 16990807
捐赠科研通 5360255
什么是DOI,文献DOI怎么找? 2847594
邀请新用户注册赠送积分活动 1825062
关于科研通互助平台的介绍 1679354